These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6911028)

  • 1. [Method of determining human and animal plasma kallikrein inhibitors].
    Surovikina MS; Fomina EE
    Biull Eksp Biol Med; 1981 May; 91(5):623-6. PubMed ID: 6911028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Method for determining kallikrein of tissue origin in blood plasma and its clinical significance].
    Surovkina MS; Semenova LV; Semenov VI; Lapshina IM; Volkova TV
    Biull Eksp Biol Med; 1985 Aug; 100(8):249-52. PubMed ID: 3849314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Method of estimating kininogenesis in blood plasma].
    Surovikina MS; Lapshina IM; Maslikova GV; Drozdova GA; Vasil'ev AN
    Biull Eksp Biol Med; 1983 May; 95(5):115-8. PubMed ID: 6552201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct radioimmunoassay of active and inactive human glandular kallikrein: some physiological and pathological variabilities.
    Girolami JP; Pecher C; Bascands JL; Cabos-Boutot G; Vega-Vidalle C; Colle A; Adam A; Suc JM
    J Immunoassay; 1989; 10(2-3):221-36. PubMed ID: 2663924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of kininogenesis indices].
    Surovikina MS; Maslikova GV; Fomina EE
    Biull Eksp Biol Med; 1983 May; 95(5):106-9. PubMed ID: 6552200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
    Schmaier AH; Gustafson E; Idell S; Colman RW
    J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem).
    Rosatelli TB; Roselino AM; Dellalibera-Joviliano R; Reis ML; Donadi EA
    Br J Dermatol; 2005 Apr; 152(4):650-7. PubMed ID: 15840094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prekallikrein and kallikrein inhibitors in the blood plasma in viral hepatitis in children].
    Kramariev SO
    Pediatr Akus Ginekol; 1979; (6):9-11. PubMed ID: 534554
    [No Abstract]   [Full Text] [Related]  

  • 10. Prokallikrein and kallikrein inhibitors in human urine.
    Madeddu P; Oppes M; Rubattu S; Tonolo GC; Dessì-Fulgheri P; Glorioso N; Rappelli A
    J Hypertens Suppl; 1985 Dec; 3(3):S283-6. PubMed ID: 2856718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the kallikrein-kinin system in chronic hemodialysis patients].
    Jankova T; Nenov D
    Z Urol Nephrol; 1982 Feb; 75(2):81-4. PubMed ID: 6918181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat.
    Gáti T; Budavári I; Szombath D; Losonczy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor.
    Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB
    Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological method of determining total kallikrein activity in the plasma of man and laboratory animals].
    Surovikina MS
    Lab Delo; 1975; (1):5-9. PubMed ID: 45974
    [No Abstract]   [Full Text] [Related]  

  • 17. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome.
    Hernández CC; Donadi EA; Reis ML
    J Rheumatol; 1998 Dec; 25(12):2381-4. PubMed ID: 9858433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kallikrein-kinin system in acute empyema of pleura and pyopneumothorax].
    Tseĭmakh EA; Kurasov VN
    Khirurgiia (Mosk); 1999; (7):40-2. PubMed ID: 10459186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and characterization of human tissue kallikrein variants.
    Chan H; Springman EB; Clark JM
    Protein Expr Purif; 1998 Apr; 12(3):361-70. PubMed ID: 9535704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.